Erythrodermic psoriasis associated with Castleman disease: a case report
Open Access
- 30 June 2025
- journal article
- Published by The Korean Society for Psoriasis in Journal of the Korean Society for Psoriasis
- Vol. 22 (1) , 24-28
Abstract
Ko Eun Kim, Han-Na Kim, Jiehyun Jeon, Dae Sik Kim, Yoo Sang Baek. Journal of the Korean Society for Psoriasis 2025;22:24-8. https://doi.org/10.23203/JKSP.2025.22.1.24Keywords
This publication has 17 references indexed in Scilit:
- Unicentric Castleman’s disease in the parotid gland associated with psoriasis: a case reportJournal of Medical Case Reports, 2024
- Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advancesBlood Reviews, 2023
- Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosisRheumatology, 2022
- Castleman diseaseNature Reviews Disease Primers, 2021
- Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseasesJournal of Cancer Research and Clinical Oncology, 2021
- Castleman's disease in two patients with spondyloarthritis treated by Tumor Necrosis Factor-alpha antagonistsJoint Bone Spine, 2020
- International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman diseaseBlood, 2017
- Diagnosis of Castleman disease in a patient treated with prolonged anti-TNF biologic therapy for psoriasis and psoriatic arthritisJournal of the American Academy of Dermatology, 2015
- Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trialThe Lancet Oncology, 2014
- Case 40351New England Journal of Medicine, 1954